Missed GME or NVDA? Donโt Miss the Next One.โ
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ for free.
Home โบ Stocks โบ Zepp Health Corporation (ZEPP) Stock Forecast & Price Prediction Netherlands | NYSE | Technology | Consumer Electronics
$2.28
-0.04 (-1.52%)Did ZEPP Make This Month's Elite Buy List?
We don't follow just any analyst โ only the top 3% with a proven track record make our cut. See if Zepp Health is one of their latest high-conviction picks.
Wall Street analysts covering ZEPP have a bullish consensus with a median price target of $12.32 (ranging from $12.32 to $12.32). Currently trading at $2.28, the median forecast implies a 441.5% upside. This outlook is supported by 1 Buy, 0 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
These are the latest 20 analyst ratings and price targets for ZEPP.
Date | Firm | Analyst | Rating | Change | Price Target |
---|
The following stocks are similar to Zepp Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Zepp Health Corporation has a market capitalization of $33.19M with a P/E ratio of -0.5x. The company generates $181.18M in trailing twelve-month revenue with a -44.5% profit margin.
Revenue growth is -2.6% quarter-over-quarter, while maintaining an operating margin of -47.7% and return on equity of -28.6%.
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ tracked and updated every Monday and Thursday.
Develops smart wearable health technology.
Zepp Health Corporation generates revenue by designing and manufacturing smart wearable devices, such as smartwatches and fitness trackers, that cater to health-conscious consumers. Their products utilize advanced biosensors to track various physiological metrics, providing users with valuable insights into their health and fitness.
The company operates in the rapidly growing wearable technology market, driven by rising consumer interest in health and wellness. Zepp Health's focus on research and development keeps its offerings innovative and competitive, positioning it as a significant player in personal health monitoring.
Technology
Consumer Electronics
765
Mr. Wang Huang
Netherlands
2018
Zepp Health Corporation (NYSE: ZEPP) will hold its Q1 2025 Earnings Conference Call on May 19, 2025, at 9:00 PM ET, featuring key company executives.
Earnings calls provide insights into a company's financial health and future outlook. Zepp Health's Q1 2025 results will influence investor sentiment and stock performance.
Zepp Health Corporation (NYSE: ZEPP) reported its unaudited financial results for Q1 2025 on May 19, 2025.
Zepp's Q1 2025 financial results impact its valuation, profitability outlook, and market position, influencing investor sentiment and stock performance.
An earnings call is scheduled for May 19, 2025, at 9:00 p.m. ET in Milpitas, California.
The earnings call announcement signals potential insights into the company's financial performance, impacting stock valuation and investor sentiment.
Zepp Health Corporation (NYSE: ZEPP) filed its annual report on Form 20-F for the year ended December 31, 2024, with the SEC on April 25, 2025.
Zepp Health's filing of its annual report indicates transparency and compliance, providing investors with crucial financial data and insights into the company's performance and future prospects.
Amazfit has launched the Bip 6 smartwatch, featuring a 1.97-inch AMOLED display and enhanced health and heart rate monitoring capabilities.
Amazfit's launch of the Bip 6 smartwatch could enhance market share and revenue in the wearables sector, impacting sales projections and investor sentiment in tech and health markets.
Zepp Health Corporation (NYSE: ZEPP) will hold its Q4 2024 earnings conference call on March 26, 2025, at 7:00 PM ET, featuring key executives and analysts.
Zepp Health's Q4 and full-year earnings call reveals critical financial performance insights, influencing market sentiment and investment decisions in the health tech sector.
Based on our analysis of 0 Wall Street analysts, Zepp Health Corporation (ZEPP) has a median price target of $12.32. The highest price target is $12.32 and the lowest is $12.32.
According to current analyst ratings, ZEPP has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $2.28. Always conduct your own research and consider your investment goals before making investment decisions.
Wall Street analysts predict ZEPP stock could reach $12.32 in the next 12 months. This represents a 441.5% increase from the current price of $2.28. Please note that this is a projection by Wall Street analysts and not a guarantee.
Zepp Health Corporation generates revenue by designing and manufacturing smart wearable devices, such as smartwatches and fitness trackers, that cater to health-conscious consumers. Their products utilize advanced biosensors to track various physiological metrics, providing users with valuable insights into their health and fitness.
The highest price target for ZEPP is $12.32 from at , which represents a 441.5% increase from the current price of $2.28.
The lowest price target for ZEPP is $12.32 from at , which represents a 441.5% increase from the current price of $2.28.
The overall analyst consensus for ZEPP is bullish. Out of 0 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell, with a median price target of $12.32.
Stock price projections, including those for Zepp Health Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.